Skip to main content

Peer Review reports

From: DICE: Dual mTorc Inhibition in advanCed/recurrent Epithelial ovarian cancer resistant to standard treatment—a study protocol for a randomised trial investigating a novel therapy called TAK228

Original Submission
28 May 2021 Submitted Original manuscript
19 Sep 2021 Reviewed Reviewer Report - Muslim Syed
10 Dec 2021 Reviewed Reviewer Report - Matthias Briel
5 Jan 2022 Author responded Author comments - Lee Webber
Resubmission - Version 2
5 Jan 2022 Submitted Manuscript version 2
Publishing
6 Jan 2022 Editorially accepted
5 Apr 2022 Article published 10.1186/s13063-022-06201-3

You can find further information about peer review here.

Back to article page